Affylmmune Therapeutics, a Natik MA-based clinical stage biotechnology company, raised $20M in Series A+ funding.The round was led by ORI Capital (ORI). As part of the financing, Elaine Yang, Dire... 原文链接
本文新闻来源www.finsmes.com,版权归原作者所有,内容仅代表作者本人观点,不代表企查查的立场。如有任何疑问或需要删除,请联系
kefu@qichacha.com